After vaccine controversy, entity of Anvisa servers says it will not tolerate pressure

0
3
After vaccine controversy, entity of Anvisa servers says it will not tolerate pressure


The Association of National Health Surveillance Agency (Anvisa) he stated that civil servants will not tolerate pressures in the performance of their work and that vaccines against covid-19 will be evaluated according to technical and scientific standards.

The clarification was made due to the recent controversies involving the purchase of the vaccine Coronavac fur Ministry of Health. Coronavac is developed by the Chinese pharmaceutical company Sinovac in partnership with Butantã Institute.

“Regardless of origin or nationality, the products will be evaluated according to the highest technical and scientific standards, with the purpose of promoting access and protecting the health of the Brazilian people,” the Association said in a note.



Coronavac vaccine is a partnership between the Butantã Institute and the Chinese Sinovac.


© Disclosure / SP State Government
Coronavac vaccine is a partnership between the Butantã Institute and the Chinese Sinovac.

According to the entity, civil servants will not tolerate any political or ideological pressures in the work. “On this occasion, we express our support for the collegiate board of Anvisa, which has been working in favor of the Agency’s independence and autonomy.”

The agency also reinforced the commitment of Anvisa’s employees to “maintain the exemption, integrity, ethics and speed in the analysis of the regulatory processes that involve products intended to face the pandemic by the new coronavirus“, said.

LEAVE A REPLY

Please enter your comment!
Please enter your name here